CASE REPORT
Caffey-Silverman syndrome – a case report of a two-monthold
boy with a positive family history
More details
Hide details
Submission date: 2018-04-24
Final revision date: 2018-05-27
Acceptance date: 2018-06-07
Publication date: 2018-08-30
Pediatr Pol 2018;93(4):343-348
KEYWORDS
TOPICS
ABSTRACT
Caffey-Silverman disease is a rare, self-limiting disease of infancy. The onset of the disease is usually sudden, and it is characterised by the following symptoms: irritability and/or fever, painful swelling of soft tissues, and excessive bone formation – typical changes in X-ray. The disease usually occurs in the first six months of the child’s life. In most cases, well-researched clinical history, basic laboratory tests, and X-ray imaging are enough to diagnose the disease. We present a case of a two-month-old boy with clinical, radiological symptoms and a positive family history of Caffey-Silverman disease. The baby was admitted to the clinic due to left leg oedema and limitation of mobility in the left hip. In the X-ray, intensive periosteal layering along the mandible and long limb bones was seen. Genetic testing revealed a mutation in the COL1A1 gene. Although Caffey-Silverman disease is a rare collagenopathy, one should not forget its existence.
REFERENCES (23)
1.
Pytrus T, Zaleska-Dorobisz U, Piasecka A, et al. Caffey-Silverman Syndrome – case report. Adv Clin Exp Med 2005; 14: 843-848.
2.
Szwed A, Kołban M, Romanowska H, et al. Familial Occurrence of Caffey-Silverman Syndrome. Ortop Traumatol Rehabil 2012; 14: 75-83.
3.
Caffey J. Infantile cortical hyperostosis; a review of the clinical and radiographic features. J R Soc Med 1957; 50: 347-354.
4.
Özdemir ÖMA, Tancer-Elçi H, Polat A, et al. Familial mutation in Caffey disease with reduced penetrance: a case report. Turk J Pediatr 2016; 58: 650-653.
5.
Rodríguez M, Martínez LE, Cortés J, et al. Infantile cortical hyperostosis: case report. Rev Chil Pediatr 2016; 87: 401-405.
6.
Nayak C, Samal BP. Infantile cortical hyperostosis, masquerading as osteomyelitis: a case report with three year follow up and review of the literature. Int J Contemp Pediatr 2015; 2: 249-253.
7.
Prior AR, Moldovan O, Azevedo A, et al. Caffey disease in neonatal period: the importance of the family! BMJ Case Rep 2012; 10.1136/bcr-2012-006996.
8.
Gensure RC, Mäkitie O, Barclay C, et al. A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J Clin Invest 2005; 115: 1250-1257.
9.
Al Kaissi A, Petje G, De Brauwer V, et al. Professional awareness is needed to distinguish between child physical abuse from other disorders that can mimic signs of abuse (Skull base sclerosis in infant manifesting features of infantile cortical hyperostosis): a case report and review of the literature. Cases J 2009; 2: 133.
10.
Agrawal A, Purandare N, Shah S, et al. A rare variant of Caffey’s disease – X-rays, bone scan and FDG PET findings. Indian J Nucl Med 2011; 26: 112-114.
11.
Sarmento Pinheiro PCM, Aymore IL, Amoedo AR, et al. Infantile Cortical Hyperostosis: Report of a Case with Observations on Clinical Manifestations, Radiology, and Pathology with a Late Follow-Up of Eight Years. Case Rep Pediatr 2016; 2016: 2073854.
12.
Nistala H, Mäkitie O, Jüppner H. Caffey disease: new perspectives on old questions. Bone 2014; 60: 246-251.
13.
Thometz JG, DiRaimondo CA. A case of recurrent Caffey’s disease treated with naproxen. Clin Orthop 1996; 323: 304-309.
14.
Woo K, Emery J, Peabody J. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation. Pediatrics 1994; 93: 417-420.
15.
Borochowitz Z, Gozal D, Misselevitch I, et al. Familial Caffey’s disease and late recurrence in a child. Clin Genet 1991; 40: 329-335.
16.
Khanduri S, Katyal G, Goyal A, et al. Disease Sans Mandibular and Clavicular Involvement: A Rare Case Report. Cureus 2017; 9: e1170.
17.
Kutty N, Thomas D, George L, et al. Caffey Disease or Infantile Cortical Hyperostosis: A Case Report. Oman Med J 2010; 25: 134-136.
18.
ALBagshi MH, ALZoayed HI. Infantile cortical hyperostosis – a report of Saudi family. Sudan J Paediatr 2015; 15: 61-64.
19.
Talab YA, Mallouh A. Hyperostosis with hyperphosphatemia: a case report and review of the literature. J Pediatr Orthop 1988; 8: 338-341.
20.
Cerruti-Mainardi P, Venturi G, Spunton M, et al. Infantile cortical hyperostosis and COL1A1 mutation in four generations. Eur J Pediatr 2011; 170: 1385-1390.
21.
Suphapeetiporn K, Tongkobpetch S, Mahayosnond A, et al.Expanding the phenotypic spectrum of Caffey disease. Clin Genet 2007; 71: 280-284.
22.
Dutta S, Jain N, Bhattacharya A, et al. Infantile cortical hyperostosis. Indian Pediatr 2005; 42: 64-66.
23.
Heyman E, Laver J, Beer S. Prostaglandin synthetase inhibitor in Caffey disease. J Pediatr 1982; 101: 314.